Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.280
-0.070 (-5.19%)
At close: Apr 10, 2026, 4:00 PM EDT
1.289
+0.009 (0.73%)
After-hours: Apr 10, 2026, 5:48 PM EDT
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $79.25 million as of April 10, 2026. Its market cap has decreased by -11.96% in one year.
Market Cap
79.25M
Enterprise Value
-82.59M
1-Year Change
-11.96%
Ranking
Category
Stock Price
$1.28
Market Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has decreased from $737.62M to $79.25M, a decrease of -89.26%. That is a compound annual growth rate of -31.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 79.25M | 5.71% |
| Dec 31, 2025 | 74.97M | -90.65% |
| Dec 31, 2024 | 801.44M | -26.12% |
| Dec 29, 2023 | 1.08B | 15.09% |
| Dec 30, 2022 | 942.52M | 93.72% |
| Dec 31, 2021 | 486.53M | -39.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PolyPid | 82.25M |
| aTyr Pharma | 81.62M |
| Cognition Therapeutics | 80.83M |
| Champions Oncology | 79.85M |
| Seres Therapeutics | 79.76M |
| OKYO Pharma | 79.24M |
| Filana Therapeutics | 79.22M |
| Estrella Immunopharma | 78.50M |